ARS Pharmaceuticals, Inc. SEC filings SPRY

ARS Pharmaceuticals, Inc. has 549 filings in SEC EDGAR's recent list, going back to Apr 12, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

ARS Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
3 Initial insider ownership Nov 4, 2026 Oct 26, 2026
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 19, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
144 Notice of proposed sale Sep 30, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Sep 2, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 20, 2026 —
144 Notice of proposed sale Aug 20, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
3 Initial insider ownership Aug 17, 2026 Aug 17, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 14, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 12, 2026 Jun 12, 2026
4 Insider transaction Jun 12, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
3 Initial insider ownership Jun 1, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 31, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 24, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 12, 2025
4 Insider transaction Nov 14, 2025 Nov 12, 2025
144 Notice of proposed sale Nov 13, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
144/A Filing Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 1, 2025 —
4 Insider transaction Aug 22, 2025 Aug 21, 2025
4 Insider transaction Aug 22, 2025 Aug 21, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 1, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 22, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 2, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jul 1, 2025 —
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
144 Notice of proposed sale Jun 18, 2025 —
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
144 Notice of proposed sale May 20, 2025 —
4 Insider transaction Apr 8, 2025 Apr 7, 2025
144 Notice of proposed sale Apr 7, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 24, 2025 —
4 Insider transaction Mar 21, 2025 Mar 20, 2025
144 Notice of proposed sale Mar 20, 2025 —
4 Insider transaction Mar 7, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Feb 4, 2025 Feb 3, 2025
144 Notice of proposed sale Feb 3, 2025 —
4 Insider transaction Jan 7, 2025 Jan 6, 2025
144 Notice of proposed sale Jan 6, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Dec 19, 2024 Dec 17, 2024
4 Insider transaction Dec 19, 2024 Dec 17, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 11, 2024
144 Notice of proposed sale Dec 13, 2024 —
4 Insider transaction Dec 12, 2024 Dec 10, 2024
144 Notice of proposed sale Dec 12, 2024 —
4 Insider transaction Dec 11, 2024 Dec 10, 2024
4 Insider transaction Dec 11, 2024 Dec 10, 2024
144 Notice of proposed sale Dec 11, 2024 —
144 Notice of proposed sale Dec 10, 2024 —
144 Notice of proposed sale Dec 10, 2024 —
4 Insider transaction Dec 9, 2024 Dec 6, 2024
4 Insider transaction Dec 9, 2024 Dec 6, 2024
144/A Filing Dec 9, 2024 —
4 Insider transaction Dec 6, 2024 Dec 4, 2024
144 Notice of proposed sale Dec 6, 2024 —
144 Notice of proposed sale Dec 5, 2024 —
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 4, 2024 —
144 Notice of proposed sale Dec 4, 2024 —
144 Notice of proposed sale Dec 3, 2024 —
144 Notice of proposed sale Dec 2, 2024 —
144 Notice of proposed sale Dec 2, 2024 —
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
144 Notice of proposed sale Nov 15, 2024 —
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Oct 17, 2024 Oct 16, 2024
4 Insider transaction Oct 17, 2024 Oct 15, 2024
4 Insider transaction Oct 17, 2024 Oct 15, 2024
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 15, 2024 —
4 Insider transaction Oct 10, 2024 Oct 8, 2024
4 Insider transaction Oct 10, 2024 Oct 8, 2024
4 Insider transaction Sep 19, 2024 Sep 18, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
144 Notice of proposed sale Sep 18, 2024 —
4 Insider transaction Sep 12, 2024 Sep 10, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
144 Notice of proposed sale Sep 10, 2024 —
4 Insider transaction Aug 28, 2024 Aug 26, 2024
4 Insider transaction Aug 28, 2024 Aug 26, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 21, 2024 Aug 20, 2024
4 Insider transaction Aug 21, 2024 Aug 19, 2024
4 Insider transaction Aug 21, 2024 Aug 20, 2024
4 Insider transaction Aug 21, 2024 Aug 20, 2024
4 Insider transaction Aug 21, 2024 Aug 20, 2024
144 Notice of proposed sale Aug 21, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 20, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
4 Insider transaction Aug 15, 2024 Aug 13, 2024
4 Insider transaction Aug 15, 2024 Aug 13, 2024
4 Insider transaction Aug 15, 2024 Aug 13, 2024
144 Notice of proposed sale Aug 13, 2024 —
4 Insider transaction Jul 18, 2024 Jul 16, 2024
4 Insider transaction Jul 18, 2024 Jul 16, 2024
144 Notice of proposed sale Jul 16, 2024 —
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
SC 13D/A Amended ownership over 5% (active) Jun 17, 2024 —
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
SC 13D/A Amended ownership over 5% (active) Jun 11, 2024 —
144 Notice of proposed sale Jun 11, 2024 —
4 Insider transaction Jun 7, 2024 Jun 7, 2024
4/A Filing Jun 7, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction May 16, 2024 May 14, 2024
4 Insider transaction May 16, 2024 May 14, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction Apr 24, 2024 Apr 23, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SPRY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1671858
Former names
Silverback Therapeutics, Inc. (until Nov 8, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.